Day: September 2, 2021
LEI: 213800ZBKL9BHSL2K459
OSB GROUP PLC
(the Company)
Fitch Ratings initiate coverage of OSB GROUP PLC
OSB Group is pleased to announce that Fitch Ratings has published Long-Term Issuer Default Ratings (IDRs) of ‘BBB-‘ with a Stable Outlook for OSB GROUP PLC and OneSavings Bank plc.
Andy Golding, Group Chief Executive said, “This is a milestone in the development of OSB Group and this investment grade rating from Fitch confirms the strength of our business and our balance sheet”
Enquiries:
OSB GROUP PLC
Alastair Pate
Group Head of Investor Relations
Email: osbrelations@osb.co.uk t: 01634 838 973
Brunswick
Robin Wrench / Simone Selzer t: 020 7404 5959
Notes to Editors
About OSB...
No. 16/2021 – Managers’ transactions
Written by Customer Service on . Posted in Public Companies.
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K
Copenhagen, 2 September 2021 ANNOUNCEMENT no. 16/2021
Managers’ transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 2 September 2021.Name:
Joanna Lucyna Iwanowska-NielsenReason for filing:
InsiderCompany name:
Cemat A/SIdentification code and name:
ISIN DK0010271584Transaction type:
PurchaseDate:
2 September 2021Market:
Nasdaq CopenhagenNumber of traded shares:
40,000Price:
0,915Cemat A/S
Jaroslaw Pawel LipinskiCEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no....
AB Science announced today that latest clinical data on long-term survival analyses in ALS will be presented at the 2021 symposium on ALS/MND
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
AB SCIENCE TO PRESENT LATEST CLINICAL DATA ON LONG-TERM SURVIVAL ANALYSES IN AMYOTROPHIC LATERAL SCLEROSIS AT THE 2021 INTERNATIONAL SYMPOSIUM ON ALS/MND
Paris, 2 September, 2021, 6pm CET
AB Science SA (Euronext – FR0010557264 – AB) today announced that two scientific presentations in amyotrophic lateral sclerosis (ALS) will be shared at the 2021 International Symposium on ALS/MND, which is being held virtually on 7–10 December. This is the largest medical and scientific conference dedicated to advancing science in MND/ALS and is the premier event in the ALS research calendar for discussion on the latest advances in research and clinical management.
The accepted abstracts include of one oral presentation during the platform session on Clinical Trials and Trial Design, and one ePoster presentation with accompanying...
No. 15/2021 – Managers’ transactions
Written by Customer Service on . Posted in Public Companies.
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K
Copenhagen, 2 September 2021 ANNOUNCEMENT no. 15/2021
Managers’ transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 1 September 2021.Name:
Peter Taero NielsenReason for filing:
Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the companyCompany name:
Cemat A/SIdentification code and name:
ISIN DK0010271584Transaction type:
PurchaseDate:
31 August 2021Market:
Nasdaq CopenhagenNumber of traded shares:
50,000Price:
0,895Cemat A/S
Jaroslaw Pawel LipinskiCEO
This announcement has been prepared in a Danish-language and an English-language
version. In case...
No. 14/2021 – Managers’ transactions
Written by Customer Service on . Posted in Public Companies.
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K
Copenhagen, 2 September 2021 ANNOUNCEMENT no. 14/2021
Managers’ transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 1 September 2021.Name:
Joanna Lucyna Iwanowska-NielsenReason for filing:
InsiderCompany name:
Cemat A/SIdentification code and name:
ISIN DK0010271584Transaction type:
PurchaseDate:
31 August 2021Market:
Nasdaq CopenhagenNumber of traded shares:
237,314Price:
0,90Cemat A/S
Jaroslaw Pawel LipinskiCEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no. 14...
Klépierre: Klépierre publishes its first-half 2021 financial report
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
KLÉPIERRE PUBLISHESITS FIRST-HALF 2021 FINANCIAL REPORT
Paris – September 2, 2021
Klépierre announced the public release and the filing of its first-half 2021 financial report with the Autorité des marchés financiers (“AMF”) on September 2, 2021. It may be read and downloaded from the Klépierre website, www.klepierre.com, under the “Finance” section. INVESTOR RELATIONS CONTACTS
MEDIA CONTACTSArnaud Courtial, Group Head of IR and Financial Communication+33 (0)1 40 67 57 80 — arnaud.courtial@klepierre.comPaul Logerot, IR Manager +33 (0)1 40 67 53 02 — paul.logerot@klepierre.comJulia Croissant, IR Officer+33 (0)1 40 67 51 68 — julia.croissant@klepierre.com
Helene SALMON, Group Head of Corporate& Internal Communications+33 (0)1 40 67 55 16 — helene.salmon@klepierre.com
Wandrille Clermontel, Taddeo+33 (0)6...
Aéroports de Paris SA – Voting rights as of 31 August 2021
Written by Customer Service on . Posted in Public Companies.
September 2nd, 2021
Aéroports de Paris SAInformation regarding the voting rights and shares as of 31 August 2021Statement according to Article L. 233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “Autorité des Marchés Financiers”
ISIN: FR0010340141Ticker: ADPListing place: Euronext ParisMarket: Euronext Paris – Compartment A – SRDDate
Total number of shares
Total number of gross voting rights
Total number of net voting rights131/08/2021
98,960,602
171,807,654
171,791,0041 Gross voting rights less shares without voting rights
Investor Relations: Audrey Arnoux, Head of Investor Relations +33 6 61 27 07 39 – invest@adp.frPress contact: Lola Bourget, Head of Medias and Reputation Department +33 1 74 25 23 23Groupe ADP develops and manages airports, including Paris-Charles...
COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2021
Written by Customer Service on . Posted in Public Companies.
Paris, 2nd September 2021 – 17:45
COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2021Total Number of
Shares Capital
Theoretical Number of Voting Rights1
Number of Real
Voting Rights2150,179,792
150,179,792
149,005,373
(1) including own shares
(2) excluding own shares
About Coface
COFACE SA is a société anonyme (joint-stock corporation), with a Board of Directors (Conseil d’Administration) incorporated under the laws of France, and is governed by the provisions of the French Commercial Code. The Company is registered with the Nanterre Trade and Companies Register (Registre du Commerce et des Sociétés) under the number 432 413 599. The Company’s registered office is at 1 Place Costes et Bellonte, 92270 Bois Colombes, France.
At the date of...
Aedifica NV/SA: Aedifica successfully issues its inaugural €500 million Sustainability Bond
Written by Customer Service on . Posted in Public Companies.
Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels), regarding the successful issuance of its inaugural €500 million Sustainability Bond.AttachmentsPress release ENCommuniqué de presse FRPersbericht NL
Tecan launches an accelerated bookbuilding for the placement of new shares to partly refinance the acquisition of Paramit Corporation
Written by Customer Service on . Posted in Public Companies.
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
Männedorf, Switzerland, 2 September 2021 – Tecan Group Ltd. (“Tecan Group” or “Tecan”, SIX Swiss Exchange: TECN) launches an accelerated bookbuilding for the placement of up to 650,000 new registered shares (the “New Shares”) with a par value of CHF 0.10 per share (the “Share Placement”).
The net proceeds from the Share Placement will be used to partly refinance the USD 1.0 billion (CHF 920 million) acquisition of Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life science...